Central Hypothyroidism Diagnosis and Management

Diagnostic Considerations

The pattern of low T4 and low TSH indicates central hypothyroidism, requiring immediate levothyroxine replacement therapy guided by free T4 levels rather than TSH, as recommended by the Journal for ImmunoTherapy of Cancer 1, 2
Before initiating treatment, tests such as free T4 by equilibrium dialysis, ACTH and cortisol levels, gonadal hormones, and MRI of the sella with pituitary cuts should be obtained, according to the Journal for ImmunoTherapy of Cancer 1, 2
In patients with both adrenal insufficiency and hypothyroidism, corticosteroids should always be started before thyroid hormone replacement to prevent adrenal crisis, as advised by the Journal for ImmunoTherapy of Cancer 1, 2

For patients under 70 years without cardiac disease, the initial levothyroxine dose should be 1.6 mcg/kg/day, as recommended by Praxis Medical Insights 3
For patients over 70 years or with cardiac disease, the initial dose should be 25-50 mcg/day, with gradual titration, and monitoring for cardiac arrhythmias, as suggested by Praxis Medical Insights 3
Levothyroxine dose adjustments should be made in 12.5-25 mcg increments based on free T4 levels, with a wait of 6-8 weeks between adjustments, according to Praxis Medical Insights 3

Free T4 levels should be rechecked 6-8 weeks after dose adjustment, with a target range of approximately 14-19 pmol/L, as recommended by the Annals of Oncology and Praxis Medical Insights 3, 4
Once stable, free T4 levels should be monitored every 6-12 months, as suggested by Praxis Medical Insights 3
Patients with central hypothyroidism typically require lifelong hormone replacement, as stated by the Journal for ImmunoTherapy of Cancer 1, 2
Annual monitoring of other pituitary hormones may be warranted depending on the etiology, according to the Journal for ImmunoTherapy of Cancer 1

The Endocrine Society recommends checking ACTH and cortisol levels immediately in patients with suspected central hypothyroidism, as adrenal insufficiency may coexist, and corticosteroids must be started before thyroid hormone to prevent adrenal crisis 5
The American Association of Clinical Endocrinologists suggests obtaining an MRI of the sella with pituitary cuts to evaluate for hypophysitis or other pituitary pathology in patients with central hypothyroidism 5

Patients on immunotherapy, such as checkpoint inhibitors, can develop hypophysitis causing central hypothyroidism, and this requires endocrinology consultation, as recommended by the Society for Immunotherapy of Cancer 5

The combination of undetectable TSH with low free T4 definitively indicates central hypothyroidism rather than primary thyroid disease, requiring immediate evaluation for concurrent adrenal insufficiency before initiating any thyroid hormone replacement 6
Morning ACTH and cortisol levels or a 1 mcg cosyntropin stimulation test should be obtained to rule out adrenal insufficiency 6
MRI of the sella with pituitary cuts should be performed to evaluate for pituitary enlargement, stalk thickening, or suprasellar convexity characteristic of hypophysitis 6
Additional pituitary hormones, including FSH, LH, and gonadal hormones, should be assessed to evaluate for panhypopituitarism 6

Hypophysitis typically presents with headache (85% of cases) and fatigue (66%) as the most common symptoms 6
Central hypothyroidism (>90% of cases) with low TSH and low free T4 is a common feature of hypophysitis 6
Central adrenal insufficiency (>75% of cases) often coexists with hypothyroidism in patients with hypophysitis 6
Panhypopituitarism occurs in approximately 50% of patients with hypophysitis 6

If both adrenal insufficiency and hypothyroidism are confirmed, corticosteroids should be started before initiating levothyroxine to prevent adrenal crisis 6
The American College of Endocrinology recommends that patients with central hypothyroidism should have their free T4 levels monitored, rather than TSH, to guide therapy 6
Patients with confirmed adrenal insufficiency should obtain and carry a medical alert bracelet 6